Lawrence Otto Klein, Chief Business Officer at CRISPR Therapeutics AG (CRSP), sold 40,000 shares at $50.02 ($2.0M) on 2019-07-10, disclosed to the SEC on 2019-07-12.
Open-market sale of $2.0M CRSP by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.02 | 11,579 | $579K | 28.9% |
| 2 | $50.02 | 11,579 | $579K | 28.9% |
| 3 | $50.01 | 8,421 | $421K | 21.1% |
| 4 | $50.01 | 8,421 | $421K | 21.1% |
| Total | $50.02 avg | 40,000 | $2.0M | 100% |
| Filing → |
| ORKA | SELL | 2026-09-01 | $6.9M | — | Filing → |
| ORKA | SELL | 2026-06-15 | $120K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $71K | — | Filing → |